MedPath
FDA Approval

Alfuzosin Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Apotex Corp.
DUNS: 845263701
Effective Date
September 8, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Alfuzosin(10 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Apotex Inc.

209429182

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Alfuzosin Hydrochloride

Product Details

NDC Product Code
60505-2850
Application Number
ANDA079013
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 8, 2023
AlfuzosinActive
Code: 75046A1XTNClass: ACTIBQuantity: 10 mg in 1 1
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
HYPROMELLOSE 2208 (4000 MPA.S)Inactive
Code: 39J80LT57TClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYVINYL ACETATE PHTHALATEInactive
Code: 58QVG85GW3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath